Paroxetine 20 mg

DRUG3 trials

Sponsors

Forest Laboratories, H. Lundbeck A/S, Jules Desmeules

Conditions

HealthyMajor Depressive Disorder

Phase 1

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

CompletedNCT02097147

Forest LaboratoriesHealthy

Start: 2014-03-31End: 2014-11-30Updated: 2015-02-12

Phase 3

Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

CompletedNCT02279966

H. Lundbeck A/SMajor Depressive Disorder

Start: 2014-10-31End: 2016-02-29Updated: 2017-02-28

Unknown Phase

Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6

CompletedNCT03054220

Jules DesmeulesHealthy

Start: 2016-07-31End: 2018-12-31Updated: 2019-04-19

Related Papers

Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings

Journal of Affective Disorders2018-11-059 citations